Changzhou Qianhong Biopharma CO.,LTD (002550.SZ)
CNY 5.68
(1.25%)
CNY 5.68
(1.25%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 748.4 Million CNY | -18.23% |
| 2022 | 888.96 Million CNY | 6.64% |
| 2021 | 833.62 Million CNY | 4.99% |
| 2020 | 794 Million CNY | -0.98% |
| 2019 | 801.86 Million CNY | 24.09% |
| 2018 | 646.19 Million CNY | 17.15% |
| 2017 | 551.57 Million CNY | 9.8% |
| 2016 | 502.35 Million CNY | -1.24% |
| 2015 | 508.68 Million CNY | 6.38% |
| 2014 | 478.18 Million CNY | 30.48% |
| 2013 | 366.47 Million CNY | 15.17% |
| 2012 | 318.19 Million CNY | 6.89% |
| 2011 | 297.69 Million CNY | -3.41% |
| 2010 | 308.18 Million CNY | 18.15% |
| 2009 | 260.85 Million CNY | 37.45% |
| 2008 | 189.77 Million CNY | 74.14% |
| 2007 | 108.98 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 245.03 Million CNY | 73.87% |
| 2024 Q3 | 201.43 Million CNY | 5.26% |
| 2024 Q2 | 191.37 Million CNY | -21.9% |
| 2023 FY | 726.92 Million CNY | -18.23% |
| 2023 Q2 | 203.06 Million CNY | -14.93% |
| 2023 Q1 | 238.71 Million CNY | -0.17% |
| 2023 Q4 | 140.92 Million CNY | -24.88% |
| 2023 Q3 | 187.6 Million CNY | -7.61% |
| 2022 FY | 888.96 Million CNY | 6.64% |
| 2022 Q3 | 215.94 Million CNY | 2.66% |
| 2022 Q2 | 210.35 Million CNY | -5.9% |
| 2022 Q1 | 223.53 Million CNY | 3.15% |
| 2022 Q4 | 239.12 Million CNY | 10.73% |
| 2021 Q4 | 216.7 Million CNY | -7.6% |
| 2021 Q1 | 174.32 Million CNY | -24.73% |
| 2021 Q3 | 234.52 Million CNY | 12.71% |
| 2021 FY | 833.62 Million CNY | 4.99% |
| 2021 Q2 | 208.08 Million CNY | 19.36% |
| 2020 Q4 | 231.6 Million CNY | -12.36% |
| 2020 Q3 | 264.27 Million CNY | 16.99% |
| 2020 Q2 | 225.88 Million CNY | 212.67% |
| 2020 FY | 794 Million CNY | -0.98% |
| 2020 Q1 | 72.24 Million CNY | -71.22% |
| 2019 Q1 | 170.25 Million CNY | 5.33% |
| 2019 FY | 801.86 Million CNY | 24.09% |
| 2019 Q4 | 251.05 Million CNY | 38.31% |
| 2019 Q3 | 181.51 Million CNY | -8.8% |
| 2019 Q2 | 199.02 Million CNY | 16.9% |
| 2018 Q1 | 154.07 Million CNY | -3.28% |
| 2018 FY | 646.19 Million CNY | 17.15% |
| 2018 Q4 | 161.64 Million CNY | -5.7% |
| 2018 Q3 | 171.4 Million CNY | 7.75% |
| 2018 Q2 | 159.07 Million CNY | 3.25% |
| 2017 Q3 | 126.2 Million CNY | -12.22% |
| 2017 Q1 | 122.32 Million CNY | -21.63% |
| 2017 FY | 551.57 Million CNY | 9.8% |
| 2017 Q2 | 143.76 Million CNY | 17.52% |
| 2017 Q4 | 159.28 Million CNY | 26.22% |
| 2016 FY | 502.35 Million CNY | -1.24% |
| 2016 Q1 | 96.08 Million CNY | -39.79% |
| 2016 Q3 | 117.73 Million CNY | -11.1% |
| 2016 Q2 | 132.43 Million CNY | 37.83% |
| 2016 Q4 | 156.09 Million CNY | 32.58% |
| 2015 Q2 | 120.49 Million CNY | 24.53% |
| 2015 FY | 508.68 Million CNY | 6.38% |
| 2015 Q4 | 159.57 Million CNY | 21.03% |
| 2015 Q3 | 131.84 Million CNY | 9.42% |
| 2015 Q1 | 96.76 Million CNY | -33.37% |
| 2014 Q2 | 109.38 Million CNY | 15.72% |
| 2014 Q4 | 145.22 Million CNY | 12.53% |
| 2014 FY | 478.18 Million CNY | 30.48% |
| 2014 Q1 | 94.51 Million CNY | -4.8% |
| 2014 Q3 | 129.05 Million CNY | 17.99% |
| 2013 Q2 | 91.06 Million CNY | 4.21% |
| 2013 Q3 | 88.74 Million CNY | -2.54% |
| 2013 Q4 | 99.28 Million CNY | 11.87% |
| 2013 FY | 366.47 Million CNY | 15.17% |
| 2013 Q1 | 87.38 Million CNY | -11.66% |
| 2012 Q2 | 82.45 Million CNY | 34.04% |
| 2012 Q3 | 75.29 Million CNY | -8.68% |
| 2012 Q1 | 61.51 Million CNY | -11.18% |
| 2012 FY | 318.19 Million CNY | 6.89% |
| 2012 Q4 | 98.91 Million CNY | 31.36% |
| 2011 FY | 297.69 Million CNY | -3.41% |
| 2011 Q2 | 84.05 Million CNY | 14.78% |
| 2011 Q1 | 73.22 Million CNY | -18.66% |
| 2011 Q3 | 71.14 Million CNY | -15.36% |
| 2011 Q4 | 69.26 Million CNY | -2.65% |
| 2010 Q3 | 58.96 Million CNY | -16.98% |
| 2010 Q1 | 88.16 Million CNY | 16.12% |
| 2010 FY | 308.18 Million CNY | 18.15% |
| 2010 Q4 | 90.02 Million CNY | 52.67% |
| 2010 Q2 | 71.03 Million CNY | -19.43% |
| 2009 Q4 | 75.92 Million CNY | 30.8% |
| 2009 Q3 | 58.04 Million CNY | 0.0% |
| 2009 FY | 260.85 Million CNY | 37.45% |
| 2008 FY | 189.77 Million CNY | 74.14% |
| 2007 FY | 108.98 Million CNY | 0.0% |